New Jersey is allocating $22.325 million through the Reproductive Health Access Fund for fiscal year 2026 to expand and protect reproductive health services.
The funding includes $8 million to support reproductive health providers targeted by federal policy, $5.5 million for facility and technology upgrades at clinics, and $1 million for security enhancements, according to a Dec. 24 news release from Gov. Phil Murphy’s office.
An additional $2 million will be used to expand clinical training programs in partnership with Rutgers University in New Brunswick to upskill and train healthcare workers, and $1 million will be used for recruitment incentives to attract out-of-state providers.
Other allocations include $3 million distributed through the Primary Care Practitioners Loan Redemption Program, with priority given to providers in underserved communities, $650,000 for patient outreach, and $500,000 to support strategic stockpiles of essential medications and supplies. The remaining $675,000 will be reserved to address emerging threats.
The investment is part of a broader state strategy to counter federal regulatory shifts that could jeopardize reproductive care, including proposed elimination of Title X funding and Medicaid reimbursements to Planned Parenthood.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
